HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,874,000 | +49.0% | 69,917 | 0.0% | 0.07% | +24.6% |
| Q1 2020 | $1,258,000 | -51.5% | 69,917 | -65.0% | 0.06% | -43.0% |
| Q1 2017 | $2,592,000 | +31.2% | 200,000 | 0.0% | 0.10% | +19.0% |
| Q4 2016 | $1,976,000 | -18.2% | 200,000 | 0.0% | 0.08% | -9.7% |
| Q3 2016 | $2,416,000 | +40.0% | 200,000 | 0.0% | 0.09% | +32.9% |
| Q2 2016 | $1,726,000 | -8.9% | 200,000 | 0.0% | 0.07% | -13.6% |
| Q1 2016 | $1,894,000 | -45.4% | 200,000 | 0.0% | 0.08% | -35.7% |
| Q4 2015 | $3,466,000 | – | 200,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |